Anavex Life Sciences
AVXL
186 hedge funds and large institutions have $300M invested in Anavex Life Sciences in 2025 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 56 increasing their positions, 50 reducing their positions, and 17 closing their positions.
59% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 17
22% more call options, than puts
Call options by funds: $21.1M | Put options by funds: $17.3M
12% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 50
4% more funds holding
Funds holding: 178 → 186 (+8)
0.15% more ownership
Funds ownership: 38.06% → 38.21% (+0.15%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less capital invested
Capital invested by funds: $302M → $300M (-$1.54M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$3.43M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$3.07M |
| 3 |
SF
Summit Financial
Parsippany,
New Jersey
|
+$2.24M |
| 4 |
Jane Street
New York
|
+$2.03M |
| 5 |
BlackRock
New York
|
+$1.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$8.19M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$2.47M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.26M |
| 4 |
NL
NWAM LLC
Mercer Island,
Washington
|
-$1.52M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.28M |
AVXL Hedge Fund Activity: Q3 2025 in Review
186 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q3 2025, worth a combined $300M — down 0.51% from $302M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new AVXL positions and 17 closed out — a net gain of 10 holders — while 56 added to existing stakes and 50 trimmed.
The largest buyer was State Street, adding an estimated $3.43M. The largest seller was Invesco, cutting an estimated $8.19M.
- 186 institutional investors held Anavex Life Sciences (AVXL) as of Q3 2025, up from 178 in Q2 2025.
- Funds reported $300M of Anavex Life Sciences stock for Q3 2025, down 0.51% quarter-over-quarter.
- 27 funds opened new Anavex Life Sciences positions in Q3 2025 and 17 closed out, a net change of +10 holders.
- The largest Anavex Life Sciences buyer in Q3 2025 was State Street, an estimated $3.43M added.
- The largest Anavex Life Sciences seller in Q3 2025 was Invesco, an estimated $8.19M sold.
Based on aggregated 13F filings for Q3 2025.